{"organizations": [], "uuid": "0ae62e12ac020be64eadc40c943960aa3b99ca48", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/finance/futures", "section_title": "Futures - Markets | Reuters.com", "url": "https://www.reuters.com/article/brief-dova-pharmaceuticals-reports-qtrly/brief-dova-pharmaceuticals-reports-qtrly-loss-per-share-0-36-idUSASB0C628", "country": "US", "domain_rank": 408, "title": "Dova Pharmaceuticals Reports Qtrly Loss Per Share $‍0.36​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.094, "site_type": "news", "published": "2018-02-16T05:35:00.000+02:00", "replies_count": 0, "uuid": "0ae62e12ac020be64eadc40c943960aa3b99ca48"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-dova-pharmaceuticals-reports-qtrly/brief-dova-pharmaceuticals-reports-qtrly-loss-per-share-0-36-idUSASB0C628", "ord_in_thread": 0, "title": "Dova Pharmaceuticals Reports Qtrly Loss Per Share $‍0.36​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters) - dova pharmaceuticals inc", "sentiment": "neutral"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 15 (Reuters) - Dova Pharmaceuticals Inc:\n* DOVA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 OPERATING AND FINANCIAL RESULTS\n* DOVA PHARMACEUTICALS INC QTRLY LOSS PER SHARE $‍0.36​ ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-16T05:35:00.000+02:00", "crawled": "2018-02-15T23:40:23.013+02:00", "highlightTitle": ""}